Drug Targets for Ebola, Dengue, and Zika Viruses Found in Lab Study
Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
University of California San Francisco
Give to UCSFScientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.
A UCSF surgeon is among a handful nationwide who are pioneering and studying the outcomes of a new approach to breast reconstruction.
UC San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million to address the root causes of asthma in children in Puerto Rico.
UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
Using a mouse model, researchers showed that a drug that temporarily suppresses a key component of the brain’s immune system can prevent radiation-associated cognitive decline.
Study found that simple cysts are normal, extremely common and aren’t linked to a higher risk of ovarian cancer. As a result, unless they are symptomatic, simple cysts can be safely ignored.
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend.
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry’s own data and are likely to be misunderstood by consumers.
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains.
Ten UCSF postdocs competed to explain complex research in simple language – and in three minutes or less – in the third annual Postdoc Slam held Sept. 26.
The 23rd International AIDS conference, AIDS2020, is returning to the Bay Area for the first time in 30 years, with leadership from UCSF and the International AIDS Society.
The National Institutes of Health has awarded six NIH Director’s Awards to early-career UCSF scientists – a record number for the University.
UCSF’s Max Krummel was a graduate student in the laboratory of Nobel Prize winner James P. Allison, PhD. Now Krummel is leading an ambitious project at UCSF to expand immunology and immunotherapy to understand and potentially treat new diseases.
UCSF Health and John Muir Health signed a letter of intent to develop a cancer network designed to improve prevention, diagnosis and treatment for patients throughout the East Bay.
Nearly 300 hundred experts gathered at UCSF’s Mission Bay campus to discuss the global health emergency that is climate change and to call for action to protect human health and well-being.
UCSF has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products.
Global and local leaders—including Ban Ki-moon, Mary Robinson and Eric Goosby, MD—gathered with community members at ZSFG to discuss universal health care in California and beyond.
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
UCSF researchers have discovered how a mutation in a gene regulator called the TERT promoter confers “immortality” on tumor cells, enabling the unchecked cell division that powers their aggressive growth.
Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
UCSF Benioff Children’s Hospitals are part of a nationwide campaign to shine a spotlight on childhood cancer during Pediatric Cancer Awareness Month in September—with the color gold as the campaign’s symbol.
UCSF researchers found that 58 percent of women who resided in a nursing home for more than 90 days before breast cancer surgery experienced significant functional decline one year after surgery.
In these patients, chronic tissue inflammation causes an over-active protein to introduce mutations across the genome, some of which eventually lead to cancer.
Use of e-cigarettes every day can nearly double the odds of a heart attack, according to a new analysis of a survey of nearly 70,000 people, led by researchers at UCSF.